Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, SP, Brazil; Hepatology and Liver Transplantation, A. C. Camargo Cancer Center, São Paulo, SP, Brazil.
Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, SP, Brazil; Hepatology and Liver Transplantation, A. C. Camargo Cancer Center, São Paulo, SP, Brazil.
J Pediatr Surg. 2024 Sep;59(9):1784-1790. doi: 10.1016/j.jpedsurg.2024.02.010. Epub 2024 Feb 19.
Currently, graft options for pediatric liver transplantation (PLT) include whole (WL) and partial (P) grafts, in the form of either deceased donor transplantation (DD) or living donor liver transplantation (LD). WL transplants from LD are commonly referred to as domino LT. The objective of this manuscript is to compare the outcomes of PLT performed with each of the available graft options.
Retrospective cohort study from Jan. 2010 to Dec. 2022. The variables included data on the recipients' preoperative clinical status, intraoperative technical aspects, post-operative complications, and survival studies. There were 4 groups: SPLIT (17), DD-WL (55), LD-WL (824), and LD-P (22).
The median age and BW of the recipients was smaller in SPLIT, LD-P, and LD-WL compared to DDT-WL groups. HVOO (HR 15.87, 95% CI 1.89-133.06, P = 0.01), retransplantation (HR 7.94, 95% CI 2.63-24.02, P < 0.01), and malignancies (HR 3.08, 95% CI 1.29-7.37, P = 0.01) were independently associated with decreased patient survival. HAT (HR 27.54, 95% CI 10.44-72.68, P < 0.01) and malignancies (HR 2.42, 95% CI 1.10-5.34, P = 0.03) increased the risk of graft loss. The overall survival in this series was 91.4% (mean follow-up of 74.3 months). Patient and graft survival were not different among groups.
HAT and malignancies were associated with reduced graft survival. Whole liver from living donors with MSUD presented 100% patient survival at 120 months. Even without statistical differences in survival among the studied groups, LD-P and LD-WL recipients presented a trend towards better outcomes.
LEVEL III.
目前,小儿肝移植(PLT)的移植物选择包括全肝(WL)和部分肝(P)移植物,形式为已故供体移植(DD)或活体供体肝移植(LD)。LD 来源的 WL 移植物通常被称为 Domino LT。本手稿的目的是比较使用每种可用移植物选择进行 PLT 的结果。
这是一项 2010 年 1 月至 2022 年 12 月的回顾性队列研究。研究变量包括接受者术前临床状况、术中技术方面、术后并发症和生存研究的数据。共有 4 组:SPLIT(17)、DD-WL(55)、LD-WL(824)和 LD-P(22)。
与 DD-WL 组相比,SPLIT、LD-P 和 LD-WL 组的接受者中位年龄和体重较小。HVOO(HR 15.87,95%CI 1.89-133.06,P=0.01)、再次移植(HR 7.94,95%CI 2.63-24.02,P<0.01)和恶性肿瘤(HR 3.08,95%CI 1.29-7.37,P=0.01)与患者生存率降低独立相关。HAT(HR 27.54,95%CI 10.44-72.68,P<0.01)和恶性肿瘤(HR 2.42,95%CI 1.10-5.34,P=0.03)增加了移植物丢失的风险。本系列的总体生存率为 91.4%(平均随访 74.3 个月)。各组患者和移植物生存率无差异。
HAT 和恶性肿瘤与移植物生存率降低相关。MSUD 患者的活体供体全肝在 120 个月时达到 100%患者生存率。尽管在研究组之间的生存中没有统计学差异,但 LD-P 和 LD-WL 接受者的结果呈现出更好的趋势。
III 级。